Print Friendly Page

Protocol No. ALTE07C1

Principal Investigator DeSantes, Kenneth

Phase N/A

Age Group Both

Scope National

Sponsor Type National

Title Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer

Objective The overall goal of this study is to learn about the neuropsychological (for example, thinking, learning,and remembering) and behavioral functioning of children being treated for cancer.
Another goal of this study is to find out if a standard set (called a battery) of neuropsychological and behavioral tests can be consistently completed at all the COG hospitals and at 3 standard time points.

Treatment As part of this study, all patients will have 3 testing sessions, each lasting about 1 hour. The first assessment will take place around 9 months after you have been diagnosed with cancer (during your cancer treatment). The second assessment will take place around 30 months (that is 2.5 years) after you have been diagnosed with cancer. The third assessment will take place around 60 months (that is 5 years) after you have been diagnosed with cancer. The second and third assessments will look at changes after your cancer treatment.

Key Eligibility
  • The patient must currently be enrolled or plan to be enrolled on a COG therapeutic study that aims to examine neuropsychological, social, emotional, and/or behavioral functioning
  • The patient must have receptive and expressive language skills in English, French,or Spanish. If a patient meets these criteria but the parent/guardian speaks a language other than English, French, or Spanish, the patient may still be enrolled and tested, and the parent-report measures should be omitted
    EXCLUSION:
  • Patients with a history of moderate to profound intellectual disability (i.e. IQ < 55) are not eligible for enrollment. PLEASE NOTE: Children with a prior history of attention deficit hyperactivity disorder (ADHD) or a specific learning disability (e.g., dyslexia) are eligible for this study

  • Applicable Disease Sites Brain/Central Nervous System; Leukemia

    Status Open

    Participating Institutions Gundersen Health System; UW Hospital and Clinics